{"pmid":32422085,"title":"Cytokine Levels in the Body Fluids of a Patient With COVID-19 and Acute Respiratory Distress Syndrome: A Case Report.","text":["Cytokine Levels in the Body Fluids of a Patient With COVID-19 and Acute Respiratory Distress Syndrome: A Case Report.","Ann Intern Med","Wang, Changsong","Kang, Kai","Gao, Yan","Ye, Ming","Lan, Xiuwen","Li, Xueting","Zhao, Mingyan","Yu, Kaijiang","32422085"],"journal":"Ann Intern Med","authors":["Wang, Changsong","Kang, Kai","Gao, Yan","Ye, Ming","Lan, Xiuwen","Li, Xueting","Zhao, Mingyan","Yu, Kaijiang"],"date":"2020-05-19T11:00:00Z","year":2020,"_id":"32422085","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.7326/L20-0354","topics":["Case Report"],"weight":1,"_version_":1667159284507475968,"score":9.490897,"similar":[{"pmid":32426242,"pmcid":"PMC7229956","title":"Novel coronavirus-related acute respiratory distress syndrome in a patient with twin pregnancy: A case report.","text":["Novel coronavirus-related acute respiratory distress syndrome in a patient with twin pregnancy: A case report.","We present the case of a 39-year-old woman, G1P0, who had conceived twins via in-vitro fertilization, who presented at 27weeks of gestation with nasal congestion and dry cough for 7days. On presentation, her physical examination was benign, except for sinus tachycardia, and she was oxygenating adequately on room air. Laboratory studies were unremarkable, except a PCR test positive for SARS-COV2, and a CT scan of her chest showed bilateral multi-focal ground-glass opacities. A fetal non-stress test was reassuring. She was treated with intravenous fluids, ceftriaxone, azithromycin, and hydroxychloroquine. During her hospital stay, she developed progressively worsening respiratory failure, initially requiring non-invasive ventilation, and subsequently progressed to acute respiratory distress syndrome requiring mechanical ventilation. She then suffered from sudden hypoxemia and hemodynamic collapse, on maximal ventilatory support, prompting an emergency cesarean section at bedside. This led to rapid stabilization of hemodynamic parameters, and of her overall respiratory status. Both the twins were born prematurely, and one of them tested positive for SARS-COV2.","Case Rep Womens Health","Mehta, Harsh","Ivanovic, Sasa","Cronin, Amanda","VanBrunt, Lindsey","Mistry, Nirav","Miller, Richard","Yodice, Paul","Rezai, Fariborz","32426242"],"abstract":["We present the case of a 39-year-old woman, G1P0, who had conceived twins via in-vitro fertilization, who presented at 27weeks of gestation with nasal congestion and dry cough for 7days. On presentation, her physical examination was benign, except for sinus tachycardia, and she was oxygenating adequately on room air. Laboratory studies were unremarkable, except a PCR test positive for SARS-COV2, and a CT scan of her chest showed bilateral multi-focal ground-glass opacities. A fetal non-stress test was reassuring. She was treated with intravenous fluids, ceftriaxone, azithromycin, and hydroxychloroquine. During her hospital stay, she developed progressively worsening respiratory failure, initially requiring non-invasive ventilation, and subsequently progressed to acute respiratory distress syndrome requiring mechanical ventilation. She then suffered from sudden hypoxemia and hemodynamic collapse, on maximal ventilatory support, prompting an emergency cesarean section at bedside. This led to rapid stabilization of hemodynamic parameters, and of her overall respiratory status. Both the twins were born prematurely, and one of them tested positive for SARS-COV2."],"journal":"Case Rep Womens Health","authors":["Mehta, Harsh","Ivanovic, Sasa","Cronin, Amanda","VanBrunt, Lindsey","Mistry, Nirav","Miller, Richard","Yodice, Paul","Rezai, Fariborz"],"date":"2020-05-20T11:00:00Z","year":2020,"_id":"32426242","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1016/j.crwh.2020.e00220","keywords":["acute respiratory distress syndrome","covid-19","mechanical ventilation","novel coronavirus disease","twin pregnancy","vertical transmission"],"e_drugs":["Ceftriaxone","Azithromycin","Hydroxychloroquine"],"topics":["Case Report"],"weight":1,"_version_":1667252838014648321,"score":49.430805},{"pmid":32085846,"pmcid":"PMC7164771","title":"Pathological findings of COVID-19 associated with acute respiratory distress syndrome.","text":["Pathological findings of COVID-19 associated with acute respiratory distress syndrome.","Lancet Respir Med","Xu, Zhe","Shi, Lei","Wang, Yijin","Zhang, Jiyuan","Huang, Lei","Zhang, Chao","Liu, Shuhong","Zhao, Peng","Liu, Hongxia","Zhu, Li","Tai, Yanhong","Bai, Changqing","Gao, Tingting","Song, Jinwen","Xia, Peng","Dong, Jinghui","Zhao, Jingmin","Wang, Fu-Sheng","32085846"],"journal":"Lancet Respir Med","authors":["Xu, Zhe","Shi, Lei","Wang, Yijin","Zhang, Jiyuan","Huang, Lei","Zhang, Chao","Liu, Shuhong","Zhao, Peng","Liu, Hongxia","Zhu, Li","Tai, Yanhong","Bai, Changqing","Gao, Tingting","Song, Jinwen","Xia, Peng","Dong, Jinghui","Zhao, Jingmin","Wang, Fu-Sheng"],"date":"2020-02-23T11:00:00Z","year":2020,"_id":"32085846","source":"PubMed","week":"20208|Feb 17 - Feb 23","doi":"10.1016/S2213-2600(20)30076-X","link_erratum_in":"32109426","topics":["Case Report"],"weight":1,"_version_":1666138492937175043,"score":43.63583},{"pmid":32395910,"title":"Contrast-Enhanced Ultrasound in Patients With COVID-19: Pneumonia, Acute Respiratory Distress Syndrome, or Something Else?","text":["Contrast-Enhanced Ultrasound in Patients With COVID-19: Pneumonia, Acute Respiratory Distress Syndrome, or Something Else?","Coronavirus disease 2019 (COVID-19) represents a very heterogeneous disease. Some aspects of COVID-19 pneumonia question the real nature of ground glass opacities and its consolidative lesions. It has been hypothesized that COVID-19 lung involvement could represent not only a viral effect but also an immune response induced by the infection, causing epithelial/endothelial lesions and coagulation disorders. We report 3 cases of COVID-19 pneumonia in which contrast-enhanced ultrasound was suggestive of consolidations with perfusion defects, at least in part caused by ischemic or necrotic changes and not only by inflammatory or atelectasis events.","J Ultrasound Med","Soldati, Gino","Giannasi, Gianfranco","Smargiassi, Andrea","Inchingolo, Riccardo","Demi, Libertario","32395910"],"abstract":["Coronavirus disease 2019 (COVID-19) represents a very heterogeneous disease. Some aspects of COVID-19 pneumonia question the real nature of ground glass opacities and its consolidative lesions. It has been hypothesized that COVID-19 lung involvement could represent not only a viral effect but also an immune response induced by the infection, causing epithelial/endothelial lesions and coagulation disorders. We report 3 cases of COVID-19 pneumonia in which contrast-enhanced ultrasound was suggestive of consolidations with perfusion defects, at least in part caused by ischemic or necrotic changes and not only by inflammatory or atelectasis events."],"journal":"J Ultrasound Med","authors":["Soldati, Gino","Giannasi, Gianfranco","Smargiassi, Andrea","Inchingolo, Riccardo","Demi, Libertario"],"date":"2020-05-13T11:00:00Z","year":2020,"_id":"32395910","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.1002/jum.15338","keywords":["covid-19","contrast-enhanced ultrasound","lung ultrasound"],"topics":["Case Report"],"weight":1,"_version_":1666627827820134400,"score":42.692646},{"pmid":32343968,"pmcid":"PMC7195070","title":"Use of Tocilizumab for COVID-19-Induced Cytokine Release Syndrome: A Cautionary Case Report.","text":["Use of Tocilizumab for COVID-19-Induced Cytokine Release Syndrome: A Cautionary Case Report.","Novel coronavirus disease 2019 (COVID-19) emerged in late December 2019 in Wuhan, China. Since then, COVID-19 has become a pandemic affecting more than 1.5 million people worldwide. Patients with COVID-19 have a wide spectrum of manifestations, one being cytokine release syndrome (CRS) and its fatal correlate, secondary hemophagocytic lymphohistiocytosis (sHLH). Anti-cytokine therapy such as tocilizumab, an IL-6 receptor antagonist, is a potential treatment for COVID-19; however, data regarding the efficacy of this anti-IL-6 therapy are currently lacking. We report two cases of patients who received a diagnosis of COVID-19 complicated by CRS and were treated with tocilizumab. Both patients progressed to sHLH despite treatment with tocilizumab, and one developed viral myocarditis, challenging the safety and clinical usefulness of tocilizumab in the treatment of COVID-19-induced CRS. These cases highlight the need for clinical trials to determine optimal patient selection and timing for the use of tocilizumab during this disease process.","Chest","Radbel, Jared","Narayanan, Navaneeth","Bhatt, Pinki J","32343968"],"abstract":["Novel coronavirus disease 2019 (COVID-19) emerged in late December 2019 in Wuhan, China. Since then, COVID-19 has become a pandemic affecting more than 1.5 million people worldwide. Patients with COVID-19 have a wide spectrum of manifestations, one being cytokine release syndrome (CRS) and its fatal correlate, secondary hemophagocytic lymphohistiocytosis (sHLH). Anti-cytokine therapy such as tocilizumab, an IL-6 receptor antagonist, is a potential treatment for COVID-19; however, data regarding the efficacy of this anti-IL-6 therapy are currently lacking. We report two cases of patients who received a diagnosis of COVID-19 complicated by CRS and were treated with tocilizumab. Both patients progressed to sHLH despite treatment with tocilizumab, and one developed viral myocarditis, challenging the safety and clinical usefulness of tocilizumab in the treatment of COVID-19-induced CRS. These cases highlight the need for clinical trials to determine optimal patient selection and timing for the use of tocilizumab during this disease process."],"journal":"Chest","authors":["Radbel, Jared","Narayanan, Navaneeth","Bhatt, Pinki J"],"date":"2020-04-29T11:00:00Z","year":2020,"_id":"32343968","source":"PubMed","week":"202018|Apr 27 - May 03","doi":"10.1016/j.chest.2020.04.024","keywords":["covid-19","critical care","cytokines","viral disease"],"locations":["Wuhan","China"],"countries":["China"],"countries_codes":["CHN|China"],"e_drugs":["tocilizumab"],"topics":["Case Report"],"weight":1,"_version_":1666138495811321859,"score":41.99154},{"pmid":32384385,"title":"Acute Respiratory Distress Syndrome in a Preterm Pregnant Patient With Coronavirus Disease 2019 (COVID-19).","text":["Acute Respiratory Distress Syndrome in a Preterm Pregnant Patient With Coronavirus Disease 2019 (COVID-19).","BACKGROUND: Data suggest that pregnant women are not at elevated risk of acquiring severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection or developing severe disease compared with nonpregnant patients. However, management of pregnant patients who are critically ill with coronavirus disease 2019 (COVID-19) infection is complicated by physiologic changes and other pregnancy considerations and requires balancing maternal and fetal well-being. CASE: We report the case of a patient at 28 weeks of gestation with acute respiratory distress syndrome (ARDS) from COVID-19 infection, whose deteriorating respiratory condition prompted delivery. Our patient's oxygenation and respiratory mechanics improved within hours of delivery, though she required prolonged mechanical ventilation until postpartum day 10. Neonatal swabs for SARS-CoV-2 and COVID-19 immunoglobulin (Ig) G and IgM were negative. CONCLUSION: We describe our multidisciplinary management of a preterm pregnant patient with ARDS from COVID-19 infection and her neonate.","Obstet Gynecol","Blauvelt, Christine A","Chiu, Catherine","Donovan, Anne L","Prahl, Mary","Shimotake, Thomas K","George, Ronald B","Schwartz, Brian S","Farooqi, Naghma A","Ali, Syed S","Cassidy, Arianna","Gonzalez, Juan M","Gaw, Stephanie L","32384385"],"abstract":["BACKGROUND: Data suggest that pregnant women are not at elevated risk of acquiring severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection or developing severe disease compared with nonpregnant patients. However, management of pregnant patients who are critically ill with coronavirus disease 2019 (COVID-19) infection is complicated by physiologic changes and other pregnancy considerations and requires balancing maternal and fetal well-being. CASE: We report the case of a patient at 28 weeks of gestation with acute respiratory distress syndrome (ARDS) from COVID-19 infection, whose deteriorating respiratory condition prompted delivery. Our patient's oxygenation and respiratory mechanics improved within hours of delivery, though she required prolonged mechanical ventilation until postpartum day 10. Neonatal swabs for SARS-CoV-2 and COVID-19 immunoglobulin (Ig) G and IgM were negative. CONCLUSION: We describe our multidisciplinary management of a preterm pregnant patient with ARDS from COVID-19 infection and her neonate."],"journal":"Obstet Gynecol","authors":["Blauvelt, Christine A","Chiu, Catherine","Donovan, Anne L","Prahl, Mary","Shimotake, Thomas K","George, Ronald B","Schwartz, Brian S","Farooqi, Naghma A","Ali, Syed S","Cassidy, Arianna","Gonzalez, Juan M","Gaw, Stephanie L"],"date":"2020-05-09T11:00:00Z","year":2020,"_id":"32384385","source":"PubMed","week":"202019|May 04 - May 10","doi":"10.1097/AOG.0000000000003949","topics":["Case Report"],"weight":1,"_version_":1666267276724142080,"score":41.442066}]}